Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Clinical Apheresis|April 5, 2023
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special IssueLaura Connelly-Smith, Caroline R Alquist, Nicole A Aqui, et al.Advances in Therapy|April 4, 2024
Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension StudyChristopher J Patriquin, Andrija Bogdanovic, Morag Griffin, et al.Hemasphere|July 15, 2026
Switching between complement inhibitors in paroxysmal nocturnal hemoglobinuria: Analysis of strategy, efficacy, and safetyMorag Griffin, Bruno Fattizzo, Jong Wook Lee, et al.Advances in Therapy|July 28, 2025
Efficacy and Safety Maintained up to 3 Years in Adults with Paroxysmal Nocturnal Hemoglobinuria Receiving PegcetacoplanCarlos de Castro, Richard J Kelly, Morag Griffin, et al.Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Characterizing the association between complement-mediated TMA and cognitive dysfunction using MRI and neurocognitive assessmentPauline K Kosalka, Fahad Hannan, Jeff Hamilton, et al.The New England Journal of Medicine|September 10, 2015
Eculizumab in Pregnant Patients with Paroxysmal Nocturnal HemoglobinuriaRichard J Kelly, Britta Höchsmann, Jeff Szer, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 29, 2024
A Significant Contribution of the Classical Pathway of Complement in SARS-CoV-2 Neutralization of Convalescent and Vaccinee SeraPatrick Budylowski, Serena L L Chau, Arinjay Banerjee, et al.Eclinicalmedicine|April 16, 2025
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)Paul Coppo, Michael Bubenheim, Ygal Benhamou, et al.Pageof 4